Literature DB >> 21257837

Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer.

C Corner1, F Khimji, Y Tsang, M Harrison, R Glynne-Jones, R Hughes.   

Abstract

OBJECTIVES: We assessed the impact of three-dimensional (3D) conformal planning vs conventional planning of preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC) on small bowel and bladder sparing and in optimising coverage of tumour target volume.
METHODS: Conformal and conventional plans were created for 50 consecutive patients. The conformal plan delineated a gross tumour volume (GTV), a clinical target volume (CTV) 1 to cover potential subclinical disease spread, a CTV2 to outline the mesorectum and lymph node areas at risk, and a planning target volume (PTV) to cover set-up error and organ movement. The conventional plan was created using digitally reconstructed radiographs (DRRs). Patients were treated with a dose of 45 Gy in 25 fractions with concurrent chemotherapy over 5 weeks. Dose-volume histograms (DVHs) were created and compared for GTV, PTV, small bowel and bladder. The GTV was covered by the conventional plan in all patients.
RESULTS: Significant differences were shown for median PTV coverage with conformal planning compared with conventional planning: 99.2% vs 94.2% (range 95.9-100% vs 75.5-100%); p<0.05. The median volume of irradiated small bowel was significantly lower for CT plans at all DVH levels. Median bladder doses did not differ significantly.
CONCLUSION: 3D conformal CT planning is superior to conventional planning in terms of coverage of the tumour volume. It significantly reduces the volume of small bowel irradiated with no decrease in the rate of R0 resection compared with published data, and at the present time should be considered as the standard of care for rectal cancer planning.

Entities:  

Mesh:

Year:  2011        PMID: 21257837      PMCID: PMC3473846          DOI: 10.1259/bjr/33089685

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  31 in total

1.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

2.  Generic planning target margin for rectal cancer treatment setup variation.

Authors:  John M Robertson; Jonathon P Campbell; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-01-07       Impact factor: 7.038

3.  Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy.

Authors:  L L Gunderson; H Sosin
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer.

Authors:  Kathy L Baglan; Robert C Frazier; Di Yan; Raywin R Huang; Alvaro A Martinez; John M Robertson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-01-01       Impact factor: 7.038

5.  Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

Authors:  Jean-Pierre Gérard; Olivier Chapet; Chantal Nemoz; Pascale Romestaing; Françoise Mornex; Régis Coquard; Nicolas Barbet; Dan Atlan; Patrice Adeleine; Gilles Freyer
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

6.  Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid.

Authors:  A C Mak; T A Rich; T E Schultheiss; B Kavanagh; D M Ota; M M Romsdahl
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-02-01       Impact factor: 7.038

7.  A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation.

Authors:  M J Gallagher; H D Brereton; R A Rostock; J M Zero; D A Zekoski; L F Poyss; M P Richter; M M Kligerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-09       Impact factor: 7.038

8.  Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

Authors:  P Quirke; P Durdey; M F Dixon; N S Williams
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

9.  Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer.

Authors:  Vivek K Mehta; Cheryl Cho; James M Ford; C Jambalos; Joseph Poen; Albert Koong; Albert Lin; J Augusto Bastidas; Harvey Young; Eamonn P Dunphy; George Fisher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

10.  A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis.

Authors:  O Reerink; R C J Verschueren; B G Szabo; G A P Hospers; N H Mulder
Journal:  Eur J Cancer       Date:  2003-01       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.